Author:
Pool Peter E.,Singh Steven N.,Friedrich Tilman
Subject
Cardiology and Cardiovascular Medicine,General Medicine
Reference6 articles.
1. Efficacy and safety of a new selective class III antiarrhythmic agent dofetilide in paroxysmal atrial fibrillation or atrial flutter;Suttorp;Am J Cardiol,1992
2. Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter. Intravenous Dofetilide Investigators;Falk;J Am Coll Cardiol,1997
3. DIAMOND. In Meeting Highlights, XIXth Congress of the European Society of Cardiology;Ferguson;Circulation,1997
4. Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction. The original design concept of the Cardiac Arrhythmia Suppression Trial (CAST);Epstein;J Am Med Assoc,1993
5. Comparisons of efficacy and tolerance of moricizine with other antiarrhythmic agents in the treatment of chronic ventricular arrhythmias;Anderson;Am J Cardiol,1990
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献